367
Views
3
CrossRef citations to date
0
Altmetric
Research Article

In vivo KPT-350 treatment decreases cortical hyperexcitability following traumatic brain injury

, , , &
Pages 1489-1496 | Received 04 May 2020, Accepted 28 Jul 2020, Published online: 27 Aug 2020

References

  • Taylor CA, Bell JM, Breiding MJ, Xu L. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - United States, 2007 and 2013. MMWR Surveill Summ. 2017;66:1–16. doi:10.15585/mmwr.ss6609a1.
  • Salazar AM, Jabbari B, Vance SC, Grafman J, Amin D, Dillon JD. Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam head injury study. Neurology. 1985;35:1406–14.
  • Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998;338:20–24. doi:10.1056/NEJM199801013380104.
  • Asikainen I, Kaste M, Sarna S. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia. 1999;40:584–89. doi:10.1111/j.1528-1157.1999.tb05560.x.
  • Lowenstein DH. 2009. Epilepsy after head injury: an overview. Epilepsia. 50(Suppl 2):4–9. doi:10.1111/j.1528-1167.2008.02004.x
  • Andriessen TM, Jacobs B, Vos PE. Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med. 2010;14:2381–92. doi:10.1111/j.1582-4934.2010.01164.x.
  • Ward JL, Harting MT, Cox CS Jr., Mercer DW. Effects of ketamine on endotoxin and traumatic brain injury induced cytokine production in the rat. J Trauma. 2011;70:1471–79. doi:10.1097/TA.0b013e31821c38bd.
  • Readnower RD, Pandya JD, McEwen ML, Pauly JR, Springer JE, Sullivan PG. Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in rats. J Neurotrauma. 2011;28(9):1845–53. doi:10.1089/neu.2011.1755.
  • Khan M, Sakakima H, Dhammu TS, Shunmugavel A, Im Y-B, Gilg AG, Singh AK, Singh I. S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J Neuroinflammation. 2011;8(1):78. doi:10.1186/1742-2094-8-78.
  • d’Avila JC, Lam TI, Bingham D, Shi J, Won SJ, Kauppinen TM, Massa S, Liu J, Swanson RA. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J Neuroinflammation. 2012;9(1):31. doi:10.1186/1742-2094-9-31.
  • Cantu D, Walker K, Andresen L, Taylor-Weiner A, Hampton D, Tesco G, Dulla CG. Traumatic brain injury increases cortical glutamate network activity by compromising GABAergic control. Cereb Cortex. 2014:bhu041. doi:10.1093/cercor/bhu041.
  • Yang L, Benardo LS, Valsamis H, Ling DS. Acute injury to superficial cortex leads to a decrease in synaptic inhibition and increase in excitation in neocortical layer V pyramidal cells. J Neurophysiol. 2007;97:178–87. doi:10.1152/jn.01374.2005.
  • Pavlov I, Huusko N, Drexel M, Kirchmair E, Sperk G, Pitkänen A, Walker MC. Progressive loss of phasic, but not tonic, GABAA receptor-mediated inhibition in dentate granule cells in a model of post-traumatic epilepsy in rats. Neuroscience. 2011;194:208–19.
  • Lowenstein DH, Thomas MJ, Smith DH, McIntosh TK. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci. 1992;12:4846–53. doi:10.1523/JNEUROSCI.12-12-04846.1992.
  • Ding MC, Wang Q, Lo EH, Stanley GB. Cortical excitation and inhibition following focal traumatic brain injury. J Neurosci. 2011;31:14085–94. doi:10.1523/JNEUROSCI.3572-11.2011.
  • Buritica E, Villamil L, Guzmán F, Escobar MI, García-Cairasco N, Pimienta HJ. Changes in calcium-binding protein expression in human cortical contusion tissue. J Neurotrauma. 2009;26(12):2145–55. doi:10.1089/neu.2009.0894.
  • Xu D, Farmer A, Chook YM. Recognition of nuclear targeting signals by Karyopherin-beta proteins. Curr Opin Struct Biol. 2010;20:782–90. doi:10.1016/j.sbi.2010.09.008.
  • Turner JG, Sullivan DM. CRM1-mediated nuclear export of proteins and drug resistance in cancer. Curr Med Chem. 2008;15:2648–55. doi:10.2174/092986708786242859.
  • Kudo N, Khochbin S, Nishi K, Kitano K, Yanagida M, Yoshida M, Horinouchi S. Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem. 1997;272(47):29742–51. doi:10.1074/jbc.272.47.29742.
  • Guttler T, Gorlich D. Ran-dependent nuclear export mediators: a structural perspective. Embo J. 2011;30:3457–74. doi:10.1038/emboj.2011.287.
  • Kim JY, Shen S, Dietz K, He Y, Howell O, Reynolds R, Casaccia P. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci. 2010;13(2):180–89. doi:10.1038/nn.2471.
  • Li A, Zou F, Fu H, Cui G, Yan Y, Wu Q, Gu X. Upregulation of CRM1 relates to neuronal apoptosis after traumatic brain injury in adult rats. J Mol Neurosci. 2013;51(1):208–18. doi:10.1007/s12031-013-9994-7.
  • Chen Y, Samal B, Hamelink CR, Xiang CC, Chen Y, Chen M, Vaudry D, Brownstein MJ, Hallenbeck JM, Eiden LE, et al. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept. 2006;137(1–2):4–19. doi:10.1016/j.regpep.2006.06.016.
  • Tajiri N, De La Peña I, Acosta SA, Kaneko Y, Tamir S, Landesman Y, Carlson R, Shacham S, Borlongan CV. A nuclear attack on traumatic brain injury: sequestration of cell death in the nucleus. CNS Neurosci Ther. 2016;22(4):306–15. doi:10.1111/cns.12501.
  • Haines JD, Herbin O, de la Hera B, Vidaurre OG, Moy GA, Sun Q, Fung HYJ, Albrecht S, Alexandropoulos K, McCauley D, et al. Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination. Nat Neurosci. 2015;18(4):511–20. doi:10.1038/nn.3953.
  • Walker KR, Kang EL, Whalen MJ, Shen Y, Tesco G. 2012. Depletion of GGA1 and GGA3 mediates postinjury elevation of BACE1. J Neurosci. 32(30):10423–37. doi:10.1523/JNEUROSCI.5491-11.2012
  • Lighthall JW, Dixon CE, Anderson TE. Experimental models of brain injury. J Neurotrauma. 1989;6:83–97. doi:10.1089/neu.1989.6.83.
  • Mannix RC, Zhang J, Park J, Zhang X, Bilal K, Walker K, Tanzi RE, Tesco G, Whalen MJ. Age-dependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2011;31(1):351–61. doi:10.1038/jcbfm.2010.99.
  • Hunt RF, Scheff SW, Smith BN. Posttraumatic epilepsy after controlled cortical impact injury in mice. Exp Neurol. 2009;215:243–252, S0014-4886(08)00399–3. doi:10.1016/j.expneurol.2008.10.005.
  • Dulla CG, Tani H, Brill J, Reimer RJ, Huguenard JR. Gluatmate biosensor imaging reveals dysregulation of glutamatergic pathways in a model of developmental cortical malformation. Neurobiol dis. 2012;49C:232–46 p.
  • Statler KD, Scheerlinck P, Pouliot W, Hamilton M, White HS, Dudek FE. A potential model of pediatric posttraumatic epilepsy. Epilepsy Res. 2009;86(2–3):221–23. doi:10.1016/j.eplepsyres.2009.05.006.
  • Bolkvadze T, Pitkanen A. Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma. 2012;29:789–812. doi:10.1089/neu.2011.1954.
  • Helmy A, De Simoni MG, Guilfoyle MR, Carpenter KL, Hutchinson PJ. Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog Neurobiol. 2011;95:352–72. doi:10.1016/j.pneurobio.2011.09.003.
  • Frugier T, Morganti-Kossmann MC, O’Reilly D, McLean CA. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma. 2010;27:497–507. doi:10.1089/neu.2009.1120.
  • Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res. 1995;30(1):125–30. doi:10.1016/0169-328x(94)00287-o.
  • Sullivan PG, Keller JN, Bussen WL, Scheff SW. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res. 2002;949:88–96. doi:10.1016/s0006-8993(02)02968-2.
  • Larner SF, McKinsey DM, Hayes RL, KK WW. Caspase 7: increased expression and activation after traumatic brain injury in rats. J Neurochem. 2005;94:97–108. doi:10.1111/j.1471-4159.2005.03172.x.
  • Krajewska M, You Z, Rong J, Kress C, Huang X, Yang J, Kyoda T, Leyva R, Banares S, Hu Y, et al. Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS One. 2011;6(9):e24341. doi:10.1371/journal.pone.0024341.
  • Pratico D, Reiss P, Tang LX, Sung S, Rokach J, McIntosh TK. Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury. J Neurochem. 2002;80(5):894–98. doi:10.1046/j.0022-3042.2002.00777.x.
  • Paolin A, Nardin L, Gaetani P, Rodriguez Y Baena R, Pansarasa O, Marzatico F. Oxidative damage after severe head injury and its relationship to neurological outcome. Neurosurgery. 2002;51:949–954; discussion 954–945.
  • Xiong Y, Peterson PL, Verweij BH, Vinas FC, Muizelaar JP, Lee CP. Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E. J Neurotrauma. 1998;15:531–44.
  • Verweij BH, Muizelaar JP, Vinas FC, Peterson PL, Xiong Y, Lee CP. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111). Neurol Res. 1997;19:334–39.
  • Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70–82. doi:10.1016/j.neuropharm.2014.10.027.
  • Hightower RM, Reid AL, Gibbs DE, Wang Y, Widrick JJ, Kunkel LM, Kastenschmidt JM, Villalta SA, van Groen T, Chang H, et al. The SINE compound KPT-350 blocks dystrophic pathologies in DMD zebrafish and mice. Mol Ther. 2020;28:189–201.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.